CA2139517A1 - Conjugues immunologiques d'epitopes de neutralisation principaux, propres au vih - Google Patents

Conjugues immunologiques d'epitopes de neutralisation principaux, propres au vih

Info

Publication number
CA2139517A1
CA2139517A1 CA002139517A CA2139517A CA2139517A1 CA 2139517 A1 CA2139517 A1 CA 2139517A1 CA 002139517 A CA002139517 A CA 002139517A CA 2139517 A CA2139517 A CA 2139517A CA 2139517 A1 CA2139517 A1 CA 2139517A1
Authority
CA
Canada
Prior art keywords
arg
seq
gly
val
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002139517A
Other languages
English (en)
Inventor
Paul M. Keller
Anthony J. Conley
Alan R. Shaw
Beth A. Arnold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2139517A1 publication Critical patent/CA2139517A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002139517A 1992-07-20 1993-07-19 Conjugues immunologiques d'epitopes de neutralisation principaux, propres au vih Abandoned CA2139517A1 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US917,215 1978-06-20
US917,212 1978-06-23
US91721792A 1992-07-20 1992-07-20
US91721292A 1992-07-20 1992-07-20
US91721492A 1992-07-20 1992-07-20
US91721592A 1992-07-20 1992-07-20
US917,214 1992-07-20
US917,217 1992-07-20

Publications (1)

Publication Number Publication Date
CA2139517A1 true CA2139517A1 (fr) 1994-02-03

Family

ID=27505999

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002139517A Abandoned CA2139517A1 (fr) 1992-07-20 1993-07-19 Conjugues immunologiques d'epitopes de neutralisation principaux, propres au vih

Country Status (3)

Country Link
AU (1) AU4683093A (fr)
CA (1) CA2139517A1 (fr)
WO (1) WO1994002626A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2282378A (en) * 1993-09-30 1995-04-05 Merck & Co Inc Conjugates of epitopes of HIV with a protein complex from Neisseria
GB2294047A (en) * 1994-10-14 1996-04-17 Merck & Co Inc Synthetic peptides for use as epitopes specific for HIV
WO1997010844A1 (fr) * 1995-09-18 1997-03-27 United States Army Medical Research Materiel Command (Usamrmc) Procedes ameliores de production de vaccins polyvalents a sous-unites de proteosomes complexees de maniere non covalente
US7001600B1 (en) 1996-02-09 2006-02-21 The United States Of America As Represented By The Secretary Of Health And Human Services Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US6911527B1 (en) 1999-01-11 2005-06-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services HIV related peptides
AU2603100A (en) * 1999-01-11 2000-08-01 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Novel hiv related peptides
US7501486B2 (en) 2004-09-07 2009-03-10 Burnham Institute For Medical Research Peptides that selectively home to heart vasculature and related conjugates and methods
CN102558334B (zh) * 2004-09-07 2016-08-03 伯纳姆研究院 选择性锚定到心脏脉管系统上的肽和相关结合物和方法
ES2908749T3 (es) * 2012-09-27 2022-05-03 Idexx Lab Inc Método de detección del virus de Schmallenberg (SBV) y kit

Also Published As

Publication number Publication date
WO1994002626A1 (fr) 1994-02-03
AU4683093A (en) 1994-02-14

Similar Documents

Publication Publication Date Title
CA2143823C (fr) Analogues synthetiques de peptides, modifies pour la reversion, l'inversion et la reversion-inversion
CA2164818C (fr) Peptides synthetiques en tandem, vaccins contre le vih-1
US6331404B1 (en) HIV envelope polypeptides
DK174910B1 (da) Antigen, fremgangsmåde til fremstilling af antigenet, fremgangsmåde til diagnosticering samt immunogene præparater
AU640619B2 (en) Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
US5763574A (en) HIV-specific synthetic antigens and their use
US5204259A (en) Methods and systems for producing HIV antigens
US5166050A (en) Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
JP2003529319A (ja) ＨＩＶ−１ｇｐ４１を標的化する広範に中和する抗体を誘発する方法
JPH05262667A (ja) ウイルス抗原を用いるワクチン
JPH02238884A (ja) ネコ科白血病ウイルス抗原をコードする遺伝子を含有するプラスミド及び該プラスミドを含有する宿主
JP2001510039A (ja) 診断および治療に有用な呼吸器多核体ウイルスエピトープならびにそれらを含んでなる抗体
GB2196634A (en) Monoclonal antibodies to HIV and related peptides
JPH06501260A (ja) ヒト免疫不全ウィルスに対する中和抗体の誘発とワクチン接種に用いられるペプチド
CA2139517A1 (fr) Conjugues immunologiques d'epitopes de neutralisation principaux, propres au vih
IE912846A1 (en) New embodiments of the hiv principal neutralizing¹determinant
JPH03128399A (ja) エイズ用複合免疫原
GB2282379A (en) Conjugates of epitopes of HIV with a protein complex from Neisseria
US5851535A (en) Mimotopic polypeptides of Toxoplasma gondii and applications
US20060094017A1 (en) Immunogens for hiv vaccine
GB2282378A (en) Conjugates of epitopes of HIV with a protein complex from Neisseria
GB2282380A (en) Conjugate of epitopes of HIV with a protein complex from Neisseria
GB2282381A (en) Conjugates of epitopes of HIV with a protein complex from Neisseria
JPH03503639A (ja) レトロウイルスｈｉｖのペプチドｐｆ１０〜ｐｆ１９、該ペプチドの合成方法、特に診断用としてのその使用
EP0343132B1 (fr) Procédés et méthodes de production d'antigènes HIV

Legal Events

Date Code Title Description
FZDE Discontinued